A detailed history of Ifp Advisors, Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 53 shares of BCRX stock, worth $403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53
Holding current value
$403
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$7.03 - $8.43 $372 - $446
53 New
53 $0
Q2 2023

Aug 04, 2023

SELL
$6.96 - $8.81 $6 - $8
-1 Reduced 3.85%
25 $0
Q1 2023

Apr 18, 2023

SELL
$7.94 - $11.84 $43,804 - $65,321
-5,517 Reduced 99.53%
26 $0
Q4 2022

Feb 07, 2023

SELL
$10.5 - $14.2 $2,184 - $2,953
-208 Reduced 3.62%
5,543 $35,000
Q2 2022

Sep 06, 2022

BUY
$7.89 - $17.88 $45,375 - $102,827
5,751 New
5,751 $36,000
Q2 2022

Aug 12, 2022

SELL
$7.89 - $17.88 $45,375 - $102,827
-5,751 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$11.56 - $19.76 $65,579 - $112,098
5,673 Added 7273.08%
5,751 $93,000
Q4 2021

Jan 12, 2022

SELL
$11.18 - $15.46 $5,142 - $7,111
-460 Reduced 85.5%
78 $1,000
Q3 2021

Oct 06, 2021

SELL
$14.21 - $17.65 $117,715 - $146,212
-8,284 Reduced 93.9%
538 $7,000
Q2 2021

Jul 13, 2021

BUY
$9.5 - $17.24 $25,868 - $46,944
2,723 Added 44.65%
8,822 $140,000
Q1 2021

Apr 30, 2021

SELL
$7.37 - $13.61 $8,814 - $16,277
-1,196 Reduced 16.39%
6,099 $63,000
Q4 2020

Jan 25, 2021

BUY
$3.37 - $8.61 $17,170 - $43,867
5,095 Added 231.59%
7,295 $55,000
Q3 2020

Oct 29, 2020

BUY
$3.43 - $5.53 $7,546 - $12,166
2,200 New
2,200 $7,000
Q2 2020

Aug 05, 2020

BUY
$1.9 - $5.61 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$1.6 - $4.11 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

BUY
$1.59 - $3.45 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

BUY
$2.5 - $3.73 $0 - $0
0 New
0 $0
Q4 2017

Jan 24, 2018

SELL
$4.16 - $5.33 $4,160 - $5,330
-1,000 Closed
0 $0
Q2 2016

Jun 03, 2019

BUY
N/A
1,000
1,000 $3,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.42B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.